Copyright
©The Author(s) 2021.
World J Hepatol. Feb 27, 2021; 13(2): 166-186
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.166
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.166
Ref. | Procedure | Patients, n | Technical success % | Morbidity % |
Artifon et al[50], 2012 | PTBD, EUS-BD | 12, 13 | 100, 100 | 25.00, 15.30 |
Bapaye et al[51], 2013 | PTBD, EUS-BD | 26, 25 | 46.00, 92.00 | 46.00, 20.00 |
Khashab et al[52], 2015 | PTBD, EUS-BD | 51, 22 | 100, 86.40 | 39.20, 18.20 |
Dhir et al[53], 2015 | ERCP SEMS, EUS-BD | 104, 104 | 94.23, 93.26 | 8.65, 8.65 |
Ref. | Studies included | Patients, n | Procedures | Results |
Almadi et al[62], 2017 | 20 | 1713 | Endoscopic or percutaneous palliative biliary drainage with plastic stent vs SEMS | Stent patency 4.45 mo (95%CI: 0.31-8.59) in favor of SEMS; Overall survival 0.67 (95%CI: 0.66-1.99), no difference |
Moole et al[33], 2017 | 11 | 947 | Endoscopic palliative biliary drainage with plastic stent vs SEMS | Stent occlusion OR 0.48 (95%CI: 0.34-0.67) in favor of SEMS; Overall survival/time to death: (1) SEMS, 157.3 d (95%CI: 148.9-165.6), (2) Plastic, 120.6 d (95%CI: 114.3-126.9), P = 0.0024 |
Zorrón Pu et al[64], 2015 | 13 | 1133 | Endoscopic palliative biliary drainage with plastic stent vs SEMS | Stent dysfunction, RD -0.26 (95%CI: -0.32 to -0.20) in favor of SEMS; Survival longer in the SEMS group (187 d vs 162 d, P < 0.0001) |
Sawas et al[65], 2015 | 19 | 1989 | Endoscopic or percutaneous palliative biliary drainage with plastic stent vs SEMS | Stent occlusion, HR 0.42 (95%CI: 0.27-0.64) in favor of SEMS; 30-d survival, HR 0.82 (95%CI: 0.45-1.48), no difference |
Hong et al[66], 2013 | 10 | 785 | Endoscopic palliative biliary drainage with plastic stent vs SEMS | Stent patency, HR 0.37 (95%CI: 0.28-0.48) in favor of SEMS; Survival, HR 0.81 (95%CI: 0.68-0.96) in favor of SEMS |
Ref. | No. patients | Median survival, d/mo | Adjuvant therapy |
Ortner et al[106] | PDT 20, Control 19 | 493 d, 98 d | PDT -, Control - |
Zoepf et al[103] | PDT 16, Control 16 | 630 d, 210 d | PDT -, Control - |
Dumoulin et al[100] | PDT 24, Control 23 | 9.9 mo, 5.6 mo | PDT -, Control - |
Kahaleh et al[102] | PDT 19, Control 21 | 8.0 mo, 5.0 mo | PDT, CTX 11; RTX 9; CTX 11, RTX 10 |
Witzigman et al[99] | PDT 68, Control 56 | 12.0 mo, 6.4 mo | PDT, CTX 6; RTX 2; CTX 5, RTX 1 |
- Citation: Tantau AI, Mandrutiu A, Pop A, Zaharie RD, Crisan D, Preda CM, Tantau M, Mercea V. Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies. World J Hepatol 2021; 13(2): 166-186
- URL: https://www.wjgnet.com/1948-5182/full/v13/i2/166.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i2.166